About Ting Feng
Form D filings for Synnovation Therapeutics in 2023 list Ting Feng as director.
Ting Feng first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Ting Feng in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ting Feng works with at each company, as listed on that company's latest Form D.
Synnovation Therapeutics, Inc. · Form D/A, Dec 21, 2023
